Acadia Healthcare (ACHC) and DaVita (DVA) represent distinct niches within the healthcare services sector, with ACHC focusing on behavioral health and DVA dominating kidney dialysis. This comparison is particularly relevant for investors seeking exposure to defensive healthcare plays amid market volatility, as both companies exhibit resilience tied to essential medical services. Traders monitoring relative performance may find insights into momentum shifts, valuation contrasts, and sector-specific catalysts valuable for position sizing or rotation strategies in portfolios emphasizing long-term stability over cyclical swings.
Acadia Healthcare (ACHC) operates a network of inpatient psychiatric facilities, residential treatment centers, and outpatient behavioral health services across the U.S. and Puerto Rico. In recent market activity, the stock has shown volatility but staged a sharp recovery, posting year-to-date gains near 79% from 52-week lows around $11.43. Following its Q1 2026 earnings release, ACHC reported revenue of $828.8 million, up 7.6% year-over-year, with adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) at $144.2 million and EPS beating estimates at $0.37. Sentiment has been influenced by capacity expansions and same-facility revenue growth of 7.3%, though shares dipped in response to full-year guidance projecting EPS of $1.35–$1.60, tempering optimism amid broader operational pressures.
DaVita (DVA) is a leading provider of kidney dialysis services for chronic kidney failure patients, operating centers nationwide alongside lab and integrated care offerings. Recent weeks have seen steady performance, with shares trading around $154 and year-to-date returns of 36% within a 52-week range of $101–$159.42. Positive momentum stems from resilient dialysis demand and analyst upgrades, including UBS raising its price target to $190 while maintaining a Buy rating. Upcoming Q1 earnings on May 5 anticipate 20.5% EPS growth to $2.41, supported by prior quarters' revenue beats, though stagnant treatment volumes and regulatory scrutiny have introduced caution in market positioning.
Tickeron’s Trending AI Robots page curates the top-performing AI trading bots from its library of over 350 bots that trade thousands of tickers across diverse strategies, timeframes, and market conditions. Only the most suitable for current environments—selected for real-time signals, risk management, and superior metrics—earn a spot among the featured 25 trending agents. These bots showcase annualized returns ranging from 32% to 127%, win rates of 50–70%, profit factors up to 3.35, and average gains of 4–16%, spanning themes like semiconductors, data centers, industrials, and small caps with trade durations from minutes to days. Each employs unique AI/ML approaches, such as trend trading or volatility plays, enabling customization. Explore these high-conviction options to enhance your trading edge in today’s dynamic markets.
While both ACHC and DVA serve essential healthcare needs, their business models diverge: ACHC targets behavioral health with inpatient and outpatient facilities, vulnerable to reimbursement changes and capacity constraints, versus DVA’s focus on predictable dialysis volumes tied to end-stage renal disease prevalence. Growth drivers for ACHC include facility expansions amid rising mental health demand, contrasting DVA’s integrated kidney care and value-based arrangements. Recent momentum favors ACHC’s YTD surge but highlights volatility, while DVA offers steadier trends. Risk factors overlap in regulatory oversight and payer mix, with DVA facing dialysis-specific competition. Market sentiment leans toward DVA’s scale advantages, though ACHC’s smaller size enables nimbler positioning in underserved behavioral segments.
Tickeron’s AI currently leans toward DVA with higher probability due to its trend consistency, positive profitability metrics, larger market positioning, and anticipated earnings catalysts, positioning it favorably amid healthcare sector rotations despite ACHC’s impressive momentum rebound.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ACHC’s FA Score shows that 1 FA rating(s) are green whileDVA’s FA Score has 3 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ACHC’s TA Score shows that 5 TA indicator(s) are bullish while DVA’s TA Score has 4 bullish TA indicator(s).
ACHC (@Hospital/Nursing Management) experienced а +0.84% price change this week, while DVA (@Hospital/Nursing Management) price change was -0.03% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.10%. For the same industry, the average monthly price growth was +4.78%, and the average quarterly price growth was +27.33%.
ACHC is expected to report earnings on Aug 04, 2026.
DVA is expected to report earnings on Aug 05, 2026.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| ACHC | DVA | ACHC / DVA | |
| Capitalization | 2.32B | 13.5B | 17% |
| EBITDA | -725.79M | 2.71B | -27% |
| Gain YTD | 77.590 | 84.561 | 92% |
| P/E Ratio | 20.21 | 20.20 | 100% |
| Revenue | 3.37B | 13.8B | 24% |
| Total Cash | 158M | 667M | 24% |
| Total Debt | 2.67B | 13.2B | 20% |
ACHC | DVA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 17 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 54 Fair valued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 42 | |
SMR RATING 1..100 | 99 | 5 | |
PRICE GROWTH RATING 1..100 | 43 | 7 | |
P/E GROWTH RATING 1..100 | 11 | 20 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ACHC's Valuation (54) in the Medical Or Nursing Services industry is in the same range as DVA (74). This means that ACHC’s stock grew similarly to DVA’s over the last 12 months.
DVA's Profit vs Risk Rating (42) in the Medical Or Nursing Services industry is somewhat better than the same rating for ACHC (100). This means that DVA’s stock grew somewhat faster than ACHC’s over the last 12 months.
DVA's SMR Rating (5) in the Medical Or Nursing Services industry is significantly better than the same rating for ACHC (99). This means that DVA’s stock grew significantly faster than ACHC’s over the last 12 months.
DVA's Price Growth Rating (7) in the Medical Or Nursing Services industry is somewhat better than the same rating for ACHC (43). This means that DVA’s stock grew somewhat faster than ACHC’s over the last 12 months.
ACHC's P/E Growth Rating (11) in the Medical Or Nursing Services industry is in the same range as DVA (20). This means that ACHC’s stock grew similarly to DVA’s over the last 12 months.
| ACHC | DVA | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 51% |
| Stochastic ODDS (%) | 2 days ago 66% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 73% | 2 days ago 69% |
| MACD ODDS (%) | 2 days ago 65% | 2 days ago 56% |
| TrendWeek ODDS (%) | 2 days ago 65% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 60% | 2 days ago 63% |
| Advances ODDS (%) | 2 days ago 64% | 9 days ago 66% |
| Declines ODDS (%) | 19 days ago 69% | 16 days ago 56% |
| BollingerBands ODDS (%) | 2 days ago 60% | 2 days ago 65% |
| Aroon ODDS (%) | N/A | 2 days ago 72% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SGDJ | 83.80 | 0.71 | +0.85% |
| Sprott Junior Gold Miners ETF | |||
| RPV | 112.66 | 0.47 | +0.42% |
| Invesco S&P 500® Pure Value ETF | |||
| EFAS | 21.42 | -0.05 | -0.23% |
| Global X MSCI SuperDividend® EAFE ETF | |||
| QTPI | 25.50 | -0.07 | -0.26% |
| North Square Rcim Tax-Advantaged Preferred And Income Securities ETF | |||
| EVYM | 50.73 | -0.15 | -0.29% |
| Eaton Vance High Income Municipal ETF | |||
A.I.dvisor indicates that over the last year, ACHC has been loosely correlated with UHS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHC jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To ACHC | 1D Price Change % | ||
|---|---|---|---|---|
| ACHC | 100% | +1.33% | ||
| UHS - ACHC | 35% Loosely correlated | +1.04% | ||
| ASTH - ACHC | 31% Poorly correlated | +1.00% | ||
| THC - ACHC | 30% Poorly correlated | +3.58% | ||
| DVA - ACHC | 30% Poorly correlated | +0.85% | ||
| CON - ACHC | 29% Poorly correlated | -0.25% | ||
More | ||||